| PERIOD ENDING | 1-Nov-09 | 1-Aug-09 | 2-May-09 | 31-Jan-09 | | Total Revenue | 161,387 | 165,746 | 191,433 | 344,654 | | Cost of Revenue | 106,746 | 106,977 | 125,681 | 238,028 | | | Gross Profit | 54,641 | 58,769 | 65,752 | 106,626 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 76,165 | 75,767 | 79,359 | 99,642 | | Non Recurring |
-
|
-
|
-
| 15,158 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (21,524) | (16,998) | (13,607) | (8,174) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| 180 | | Earnings Before Interest And Taxes | (23,609) | (16,998) | (13,607) | (7,994) | | Interest Expense | (1,386) | 683 | 703 | 1,109 | | Income Before Tax | (22,223) | (17,681) | (14,310) | (9,103) | | Income Tax Expense | 93 | 75 | (574) | 355 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (22,316) | (17,756) | (13,736) | (9,458) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (22,316) | (17,756) | (13,736) | (9,458) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($22,316) | ($17,756) | ($13,736) | ($9,458) |
|
0.31% Nasdaq 
0.05%
Income Statement
